world. The most current safety recommendations (known at this time) for clinicians providing care for persons abusing fentanyl and fentanyl-related compounds such as "gray death" will be provided. Introduced 50 years ago, fentanyl has become the most used opioid for intraoperative anesthesia in North and South America, Europe, the Middle East, and in developed Africa and Asia. In the 1990s, use of fentanyl was expanded beyond surgery for the management of cancer pain and treatment of chronic pain. Intravenous fentanyl facilitates rapid anesthesia induction, results in less hemodynamic instability, has minimal cardiovascular adverse effects, and does not increase plasma histamines such as morphine and meperidine. Metabolized via the human cytochrome P450 (CYP3A4) isoenzyme system, onset of action and peak plasma concentrations are a function of the dosage used and method of delivery.3 In addition, fentanyl and fentanyl-related analogs have high lipid solubility. As a result, fentanyl drug can be delivered in a variety of slow release pathways such as the skin, mucous membranes, or the mouth and only small amounts of drug are needed because access to the brain is so immediate.1
THE ALLURE OF FENTANYL
During
WORLDWIDE FENTANYL EXPERIENCE
The United States is not alone in this opioid crisis. Since 2011, Germany, Finland, and the United Kingdom have also experienced outbreaks of fentanyl-related deaths. Diversion from regulated supply chains and illicit production in response to heroin shortages in Bulgaria and Slovakia have fueled the European crisis. Diversion includes inappropriate or overprescribing of opioids, pharmacy theft, sale of unused fentanyl patches, as well as misuse and sale by healthcare providers. Dark sources of fentanyl are the discarded patches retrieved from hospital and nursing home waste containers. Drug is extracted from the patch and placed in liquid for injection or inhalation. The patch is also smoked on foil, placed directly on the skin, or cut into pieces to be sucked or swallowed.4
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In this rise of fentanyl use, of deep concern is evidence suggesting that fentanyl has been weaponized. Rather than using a lethal chemical agent, it seems that the Russian military used a combination of an aerosolized fentanyl or fentanyl derivatives with an inhalation anesthetic to incapacitate Chechen rebels, holding 800 hostages at a Moscow theater in October 2002. To save hostages who were likely to be killed and incapacitate rebels, a "calmative" agent was used in the theater described as "not lethal." However, 127 of the 800 hostages died and more than 650 required hospital admission with what was diagnosed as "sleeping gas" poisoning. Treatment for opioid poisoning was delayed because components of the gas were unknown by the clinicians who tried a variety of antidotes base on the belief that a "nerve gas" was used before using naloxone.5
Illicit production of fentanyl is not confined to Mexico or China. Beginning in 1990, the first illicit fentanyl was produced in Kansas, which resulted in the seizure of 2 illicit laboratories.
From 2000 to 2005, several illicit laboratories in the United States were also closed. Because fentanyl is more potent than heroin, demand is increasing and profit margins are expanding.6
Today, opioids have become the most common element in overdose deaths in the United
States with 33 091 in 2015, with nearly 10 000 deaths of these deaths related to synthetic opioids (fentanyl and fentanyl-related products other than methadone). China and Mexico remain the primary sources for illicit fentanyl production and distribution in the United
States. Vast and effective distribution is accomplished through sales through the World Wide Web, dark web, and mail and via the interstate highway system from Mexico and Canada.6
The effects of opioid trafficking on public health are dreadful. Overdose deaths are defined as deaths from unintentional or intentional overdose of a drug, receiving the wrong drug, or taking a drug in error. Natural and semisynthetic opioids include morphine, codeine, hydrocodone, and oxycodone. Synthetic opioids excluding methadone include fentanyl, fentanyl analogs, and tramadol.7
Data provided in Table 1 
U-47700
To provide an even more powerful illicit opioid combination, U-47700 has emerged mixed with heroin and fentanyl or fentanyl and carfentanil, creating "gray death."1,13 "Gray death" seems similar to concrete mixing powder and texture ranges from chunky rocklike material to fine powder and can be injected, eaten, or smoked. At this time, it is unknown how U-47700 interacts with fentanyl, carfentanil, or heroin in the body.13 Some of the pills taken from
Prince's estate after the musician's overdose death last year contained U-47700.14 U-47700 is another synthetic opioid, with an abuse potential similar to heroin, prescription opioids, and other synthetic opioids. The drug comes in powder form and in counterfeit tablets that look like pharmaceutical opioids. The drug is sold as single agent and in combinations previously described. Because U-47700 is produced in illicit laboratories outside the United States, purity and dosage are often unknown, creating a "Russian Roulette"
scenario for any user. 
DOSING GUIDELINES FOR OPIOID PRESCRIBING
The "perfect storm" leading to the present opioid crisis began in the 1980s and through the 1990s. The "mantra" during these years was that pain was being poorly treated. The result was endless education regarding treatments for pain, adoption of pain as a vital sign, and ultimately linking patient satisfaction surveys to physician and nursing performance score cards and, in some cases, reimbursement. However, the reality was that the perfect storm lacked concrete evidence to support treatment of long-term pain for diagnoses outside cancer and palliative care. Prescribers were caught in the storm of improving patient satisfaction rather than screening for addiction and calculating the risk-benefits of opioid therapy.17
Finally, a lifeboat has appeared for clinicians trying to treat pain. 
